Publications
Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs) KU Leuven
(De)politicization dynamics in publicprivate partnerships (PPPs) University of Antwerp
Multiple accountabilities in public-private partnerships (PPPs) University of Antwerp
Understanding pre-contractual transaction costs for Public–Private Partnership infrastructure projects Vrije Universiteit Brussel
Public-private partnership model selection for dry port development University of Antwerp Ghent University
Innovations through public-private partnership procurement University of Antwerp
Public-Private Partnerships for the provision of port infrastructure Vrije Universiteit Brussel
Size-dependent features of public-private partnerships: geographical and sectorial differences, deal size and structuring, and transaction costs Vrije Universiteit Brussel KU Leuven
The purpose of this paper is to identify and to review the size-dependent features of public-private partnerships (PPP) which precedes the complex exercise of defining the characteristics of small-scale PPPs. Our paper covers deal size variability across countries, sectors and time; relationship between deal size and structuring and financing of PPPs with respect to maturity, payment mechanism, debt ratio and type of bank debt; and important ...
Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature Institute of Tropical Medicine
Pharmaceutical companies are reluctant to invest in research and development (R&D) of products for neglected tropical diseases (NTDs) mainly due to the low ability-to-pay of health insurance systems and of potential consumers. The available preventive and curative interventions for NTDs mostly rely on old technologies and products that are often not adequate. Moreover, NTDs mostly affect populations living in remote rural areas and ...